Overcoming Microenvironment-Mediated Chemoprotection through Stromal Galectin-3 Inhibition in Acute Lymphoblastic Leukemia
Environmentally-mediated drug resistance in B-cell precursor acute lymphoblastic leukemia (BCP-ALL) significantly contributes to relapse. Stromal cells in the bone marrow environment protect leukemia cells by secretion of chemokines as cues for BCP-ALL migration towards, and adhesion to, stroma. Str...
Guardado en:
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/88e52965b3874a80b7709ddfe968bb2e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:88e52965b3874a80b7709ddfe968bb2e |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:88e52965b3874a80b7709ddfe968bb2e2021-11-25T17:53:57ZOvercoming Microenvironment-Mediated Chemoprotection through Stromal Galectin-3 Inhibition in Acute Lymphoblastic Leukemia10.3390/ijms2222121671422-00671661-6596https://doaj.org/article/88e52965b3874a80b7709ddfe968bb2e2021-11-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/22/12167https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Environmentally-mediated drug resistance in B-cell precursor acute lymphoblastic leukemia (BCP-ALL) significantly contributes to relapse. Stromal cells in the bone marrow environment protect leukemia cells by secretion of chemokines as cues for BCP-ALL migration towards, and adhesion to, stroma. Stromal cells and BCP-ALL cells communicate through stromal galectin-3. Here, we investigated the significance of stromal galectin-3 to BCP-ALL cells. We used CRISPR/Cas9 genome editing to ablate galectin-3 in stromal cells and found that galectin-3 is dispensable for steady-state BCP-ALL proliferation and viability. However, efficient leukemia migration and adhesion to stromal cells are significantly dependent on stromal galectin-3. Importantly, the loss of stromal galectin-3 production sensitized BCP-ALL cells to conventional chemotherapy. We therefore tested novel carbohydrate-based small molecule compounds (Cpd14 and Cpd17) with high specificity for galectin-3. Consistent with results obtained using galectin-3-knockout stromal cells, treatment of stromal-BCP-ALL co-cultures inhibited BCP-ALL migration and adhesion. Moreover, these compounds induced anti-leukemic responses in BCP-ALL cells, including a dose-dependent reduction of viability and proliferation, the induction of apoptosis and, importantly, the inhibition of drug resistance. Collectively, these findings indicate galectin-3 regulates BCP-ALL cell responses to chemotherapy through the interactions between leukemia cells and the stroma, and show that a combination of galectin-3 inhibition with conventional drugs can sensitize the leukemia cells to chemotherapy.Somayeh S. TarighatFei FeiEun Ji JooHisham Abdel-AzimLu YangHuimin GengKhuchtumur Bum-ErdeneI. Darren GriceMark von ItzsteinHelen BlanchardNora HeisterkampMDPI AGarticleB-cell precursor ALLgalectin-3<i>lgals3</i>galectinmicroenvironmentadhesionBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 12167, p 12167 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
B-cell precursor ALL galectin-3 <i>lgals3</i> galectin microenvironment adhesion Biology (General) QH301-705.5 Chemistry QD1-999 |
spellingShingle |
B-cell precursor ALL galectin-3 <i>lgals3</i> galectin microenvironment adhesion Biology (General) QH301-705.5 Chemistry QD1-999 Somayeh S. Tarighat Fei Fei Eun Ji Joo Hisham Abdel-Azim Lu Yang Huimin Geng Khuchtumur Bum-Erdene I. Darren Grice Mark von Itzstein Helen Blanchard Nora Heisterkamp Overcoming Microenvironment-Mediated Chemoprotection through Stromal Galectin-3 Inhibition in Acute Lymphoblastic Leukemia |
description |
Environmentally-mediated drug resistance in B-cell precursor acute lymphoblastic leukemia (BCP-ALL) significantly contributes to relapse. Stromal cells in the bone marrow environment protect leukemia cells by secretion of chemokines as cues for BCP-ALL migration towards, and adhesion to, stroma. Stromal cells and BCP-ALL cells communicate through stromal galectin-3. Here, we investigated the significance of stromal galectin-3 to BCP-ALL cells. We used CRISPR/Cas9 genome editing to ablate galectin-3 in stromal cells and found that galectin-3 is dispensable for steady-state BCP-ALL proliferation and viability. However, efficient leukemia migration and adhesion to stromal cells are significantly dependent on stromal galectin-3. Importantly, the loss of stromal galectin-3 production sensitized BCP-ALL cells to conventional chemotherapy. We therefore tested novel carbohydrate-based small molecule compounds (Cpd14 and Cpd17) with high specificity for galectin-3. Consistent with results obtained using galectin-3-knockout stromal cells, treatment of stromal-BCP-ALL co-cultures inhibited BCP-ALL migration and adhesion. Moreover, these compounds induced anti-leukemic responses in BCP-ALL cells, including a dose-dependent reduction of viability and proliferation, the induction of apoptosis and, importantly, the inhibition of drug resistance. Collectively, these findings indicate galectin-3 regulates BCP-ALL cell responses to chemotherapy through the interactions between leukemia cells and the stroma, and show that a combination of galectin-3 inhibition with conventional drugs can sensitize the leukemia cells to chemotherapy. |
format |
article |
author |
Somayeh S. Tarighat Fei Fei Eun Ji Joo Hisham Abdel-Azim Lu Yang Huimin Geng Khuchtumur Bum-Erdene I. Darren Grice Mark von Itzstein Helen Blanchard Nora Heisterkamp |
author_facet |
Somayeh S. Tarighat Fei Fei Eun Ji Joo Hisham Abdel-Azim Lu Yang Huimin Geng Khuchtumur Bum-Erdene I. Darren Grice Mark von Itzstein Helen Blanchard Nora Heisterkamp |
author_sort |
Somayeh S. Tarighat |
title |
Overcoming Microenvironment-Mediated Chemoprotection through Stromal Galectin-3 Inhibition in Acute Lymphoblastic Leukemia |
title_short |
Overcoming Microenvironment-Mediated Chemoprotection through Stromal Galectin-3 Inhibition in Acute Lymphoblastic Leukemia |
title_full |
Overcoming Microenvironment-Mediated Chemoprotection through Stromal Galectin-3 Inhibition in Acute Lymphoblastic Leukemia |
title_fullStr |
Overcoming Microenvironment-Mediated Chemoprotection through Stromal Galectin-3 Inhibition in Acute Lymphoblastic Leukemia |
title_full_unstemmed |
Overcoming Microenvironment-Mediated Chemoprotection through Stromal Galectin-3 Inhibition in Acute Lymphoblastic Leukemia |
title_sort |
overcoming microenvironment-mediated chemoprotection through stromal galectin-3 inhibition in acute lymphoblastic leukemia |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/88e52965b3874a80b7709ddfe968bb2e |
work_keys_str_mv |
AT somayehstarighat overcomingmicroenvironmentmediatedchemoprotectionthroughstromalgalectin3inhibitioninacutelymphoblasticleukemia AT feifei overcomingmicroenvironmentmediatedchemoprotectionthroughstromalgalectin3inhibitioninacutelymphoblasticleukemia AT eunjijoo overcomingmicroenvironmentmediatedchemoprotectionthroughstromalgalectin3inhibitioninacutelymphoblasticleukemia AT hishamabdelazim overcomingmicroenvironmentmediatedchemoprotectionthroughstromalgalectin3inhibitioninacutelymphoblasticleukemia AT luyang overcomingmicroenvironmentmediatedchemoprotectionthroughstromalgalectin3inhibitioninacutelymphoblasticleukemia AT huimingeng overcomingmicroenvironmentmediatedchemoprotectionthroughstromalgalectin3inhibitioninacutelymphoblasticleukemia AT khuchtumurbumerdene overcomingmicroenvironmentmediatedchemoprotectionthroughstromalgalectin3inhibitioninacutelymphoblasticleukemia AT idarrengrice overcomingmicroenvironmentmediatedchemoprotectionthroughstromalgalectin3inhibitioninacutelymphoblasticleukemia AT markvonitzstein overcomingmicroenvironmentmediatedchemoprotectionthroughstromalgalectin3inhibitioninacutelymphoblasticleukemia AT helenblanchard overcomingmicroenvironmentmediatedchemoprotectionthroughstromalgalectin3inhibitioninacutelymphoblasticleukemia AT noraheisterkamp overcomingmicroenvironmentmediatedchemoprotectionthroughstromalgalectin3inhibitioninacutelymphoblasticleukemia |
_version_ |
1718411873280327680 |